Sexually Transmitted Diseases

>

Latest News

PEPFAR and Gilead Partner to Deliver Twice-Yearly Lenacapavir for HIV Prevention
PEPFAR and Gilead Partner to Deliver Twice-Yearly Lenacapavir for HIV Prevention

September 6th 2025

Up to 2 million people in low- and lower-middle-income countries may gain access to the long-acting PrEP option under a three-year, no-profit agreement.

World Sexual Health Day 2025: Advancing Global Awareness and Prevention
World Sexual Health Day 2025: Advancing Global Awareness and Prevention

September 4th 2025

Aging in HIV: A Review of Common Comorbidities in People Living With HIV
Aging in HIV: A Review of Common Comorbidities in People Living With HIV

August 20th 2025

FDA Grants Priority Review for Gepotidacin for Gonorrhea
FDA Grants Priority Review for Gepotidacin for Gonorrhea

August 12th 2025

Gilead Expands Global Access to Lenacapavir With New HIV Prevention Partnership
Gilead Expands Global Access to Lenacapavir With New HIV Prevention Partnership

July 10th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.